Luis Alvarez-Vallina (Luis Álvarez-Vallina)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Venues

Oncoimmunology

Pharmaceutics

Antibodies (Basel, Switzerland)

Science translational medicine

Aarhus Universitet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus Universitet Mar 01 2014

Denmark

Associate Professor :: Engineering

Publications

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez-Moreno, Marina Gómez-Rosel, Belén Blanco, Anaïs Jiménez-Reinoso, Andrea Mayado, Alba Pérez-Pons, Oscar Aguilar-Sopeña, Ángel Ramírez-Fernández, Alejandro Segura-Tudela, Lorena Perez-Amill, Antonio Tapia-Galisteo, Carmen Domínguez-Alonso, Laura Rubio-Pérez, Maria Jara, Francisco Solé, Oana Hangiu, Laura Almagro, Ángela Albitre, Petronila Penela, Laura Sanz, Eduardo Anguita, Antonio Valeri, Almudena García-Ortiz, Paula Rio, Manel Juan, Joaquín Martínez-López, Pedro Roda-Navarro, Beatriz Martin-Antonio, Alberto Orfao, Pablo Menéndez, Clara Bueno, Luis Alvarez-Vallina
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Science translational medicine 16 (734) (2024)
Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez-Moreno, Marina Gómez-Rosel, Belén Blanco, Anaïs Jiménez-Reinoso, Andrea Mayado, Alba Pérez-Pons, Oscar Aguilar-Sopeña, Ángel Ramírez-Fernández, Alejandro Segura-Tudela, Lorena Perez-Amill, Antonio Tapia-Galisteo, Carmen Domínguez-Alonso, Laura Rubio-Pérez, Maria Jara, Francisco Solé, Oana Hangiu, Laura Almagro, Ángela Albitre, Petronila Penela, Laura Sanz, Eduardo Anguita, Antonio Valeri, Almudena García-Ortiz, Paula Rio, Manel Juan, Joaquín Martínez-López, Pedro Roda-Navarro, Beatriz Martin-Antonio, Alberto Orfao, Pablo Menéndez, Clara Bueno, Luis Alvarez-Vallina
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Science translational medicine 16 (734) (2024)
Laura Rubio-Pérez, Susana Frago, Marta Compte, Rocío Navarro, Seandean L Harwood, Rodrigo Lázaro-Gorines, Marina Gómez-Rosel, Oana Hangiu, Noelia Silva-Pilipich, Lucía Vanrell, Cristian Smerdou, Luis Alvarez-Vallina
Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity. Antibodies (Basel, Switzerland) 13 (2) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Anaïs Jiménez-Reinoso, Magdalena Molero, Cristina Cirauqui, Belén Blanco, Eva Maria Garrido-Martin, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Ángel Ramírez-Fernández, Laura Díez-Alonso, Ángel Nuñez-Buiza, África Gónzalez-Murillo, Raquel Tobes, Eduardo Pareja, Manuel Ramírez, José Luis Rodriguez-Peralto, Irene Ferrer, Jon Zugazagoitia, Luis G Paz-Ares, Luis Alvarez-Vallina
CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Laura Rubio-Pérez, Susana Frago, Marta Compte, Rocío Navarro, Seandean L Harwood, Rodrigo Lázaro-Gorines, Marina Gómez-Rosel, Oana Hangiu, Noelia Silva-Pilipich, Lucía Vanrell, Cristian Smerdou, Luis Alvarez-Vallina
Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity. Antibodies (Basel, Switzerland) 13 (2) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez-Moreno, Marina Gómez-Rosel, Belén Blanco, Anaïs Jiménez-Reinoso, Andrea Mayado, Alba Pérez-Pons, Oscar Aguilar-Sopeña, Ángel Ramírez-Fernández, Alejandro Segura-Tudela, Lorena Perez-Amill, Antonio Tapia-Galisteo, Carmen Domínguez-Alonso, Laura Rubio-Pérez, Maria Jara, Francisco Solé, Oana Hangiu, Laura Almagro, Ángela Albitre, Petronila Penela, Laura Sanz, Eduardo Anguita, Antonio Valeri, Almudena García-Ortiz, Paula Rio, Manel Juan, Joaquín Martínez-López, Pedro Roda-Navarro, Beatriz Martin-Antonio, Alberto Orfao, Pablo Menéndez, Clara Bueno, Luis Alvarez-Vallina
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Science translational medicine 16 (734) (2024)
Anaïs Jiménez-Reinoso, Magdalena Molero, Cristina Cirauqui, Belén Blanco, Eva Maria Garrido-Martin, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Ángel Ramírez-Fernández, Laura Díez-Alonso, Ángel Nuñez-Buiza, África Gónzalez-Murillo, Raquel Tobes, Eduardo Pareja, Manuel Ramírez, José Luis Rodriguez-Peralto, Irene Ferrer, Jon Zugazagoitia, Luis G Paz-Ares, Luis Alvarez-Vallina
CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. Oncoimmunology 13 (1) (2024)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Rodrigo Lázaro-Gorines, Patricia Pérez, Ignacio Heras-Murillo, Irene Adán-Barrientos, Guillermo Albericio, David Astorgano, Sara Flores, Joanna Luczkowiak, Nuria Labiod, Seandean Lykke Harwood, Alejandro Segura-Tudela, Laura Rubio-Pérez, Yudhi Nugraha, Xiaoran Shang, Yuxing Li, Carlos Alfonso, Kaylin A Adipietro, Dinendra L Abeyawardhane, Rocío Navarro, Marta Compte, Wenbo Yu, Alexander D MacKerell, Laura Sanz, David J Weber, Francisco J Blanco, Mariano Esteban, Edwin Pozharski, Raquel Godoy-Ruiz, Inés G Muñoz, Rafael Delgado, David Sancho, Juan García-Arriaza, Luis Alvarez-Vallina
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Anaïs Jiménez-Reinoso, Néstor Tirado, Alba Martinez-Moreno, Víctor M Diaz, Marina García-Peydró, Oana Hangiu, Laura Díez-Alonso, Ángela Albitre, Petronila Penela, María Luisa Toribio, Pablo Menéndez, Luis Alvarez-Vallina, Diego Sánchez-Martínez
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers. Journal for immunotherapy of cancer 10 (12) (2022)
Anaïs Jiménez-Reinoso, Néstor Tirado, Alba Martinez-Moreno, Víctor M Diaz, Marina García-Peydró, Oana Hangiu, Laura Díez-Alonso, Ángela Albitre, Petronila Penela, María Luisa Toribio, Pablo Menéndez, Luis Alvarez-Vallina, Diego Sánchez-Martínez
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers. Journal for immunotherapy of cancer 10 (12) (2022)
Anaïs Jiménez-Reinoso, Néstor Tirado, Alba Martinez-Moreno, Víctor M Diaz, Marina García-Peydró, Oana Hangiu, Laura Díez-Alonso, Ángela Albitre, Petronila Penela, María Luisa Toribio, Pablo Menéndez, Luis Alvarez-Vallina, Diego Sánchez-Martínez
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers. Journal for immunotherapy of cancer 10 (12) (2022)
Carlos Carrasco-Padilla, Alicia Hernaiz-Esteban, Luis Alvarez-Vallina, Oscar Aguilar-Sopeña, Pedro Roda-Navarro
Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy. Pharmaceutics 15 (1) (2022)
Carlos Carrasco-Padilla, Alicia Hernaiz-Esteban, Luis Alvarez-Vallina, Oscar Aguilar-Sopeña, Pedro Roda-Navarro
Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy. Pharmaceutics 15 (1) (2022)
Carlos Carrasco-Padilla, Alicia Hernaiz-Esteban, Luis Alvarez-Vallina, Oscar Aguilar-Sopeña, Pedro Roda-Navarro
Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy. Pharmaceutics 15 (1) (2022)
Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno, Lidia Argemí-Muntadas, Patricia Fuentes, Oscar Aguilar-Sopeña, Francisco Gutierrez-Agüera, Samanta Romina Zanetti, Antonio Tapia-Galisteo, Laura Díez-Alonso, Alejandro Segura-Tudela, Maria Castellà, Berta Marzal, Sergi Betriu, Seandean Lykke Harwood, Marta Compte, Simon Lykkemark, Ainhoa Erce-Llamazares, Laura Rubio-Pérez, Anaïs Jiménez-Reinoso, Carmen Domínguez-Alonso, Maria Neves, Pablo Morales, Estela Paz-Artal, Sonia Guedan, Laura Sanz, María Luisa Toribio, Pedro Roda-Navarro, Manel Juan, Pablo Menéndez, Luis Alvarez-Vallina
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers. Cancer immunology research 10 (4) (2022)
Ángel Ramírez-Fernández, Oscar Aguilar-Sopeña, Laura Díez-Alonso, Alejandro Segura-Tudela, Carmen Domínguez-Alonso, Pedro Roda-Navarro, Luis Alvarez-Vallina, Belén Blanco
Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies. Oncoimmunology 11 (1) (2022)
Carlos Carrasco-Padilla, Alicia Hernaiz-Esteban, Luis Alvarez-Vallina, Oscar Aguilar-Sopeña, Pedro Roda-Navarro
Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy. Pharmaceutics 15 (1) (2022)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Oscar Aguilar-Sopeña, Seandean Lykke Harwood, Javier Narbona, Mariola Ferreras-Gutierrez, Rocío Navarro, Laura Martín-García, Cesáreo Corbacho, Marta Compte, Javier Lacadena, Francisco J Blanco, Patrick Chames, Pedro Roda-Navarro, Luis Alvarez-Vallina, Laura Sanz
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer. Oncoimmunology 11 (1) (2022)
Laura Sanz, Luis Alvarez-Vallina
Engineered mRNA and the Rise of Next-Generation Antibodies. Antibodies (Basel, Switzerland) 10 (4) (2021)
Belén Blanco, Carmen Domínguez-Alonso, Luis Alvarez-Vallina
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Marta Compte, Seandean L Harwood, Ainhoa Erce-Llamazares, Antonio Tapia-Galisteo, Eduardo Romero, Irene Ferrer, Eva Maria Garrido-Martin, Ana B Enguita, María Carmen Ochoa, Belén Blanco, Marta Oteo, Nekane Merino, Daniel Nehme-Álvarez, Oana Hangiu, Carmen Domínguez-Alonso, Manuela Zonca, Angel Ramírez-Fernández, Francisco J Blanco, Miguel Ángel Morcillo Alonso, Ines G Muñoz, Ignacio Melero, José L Rodriguez-Peralto, Luis Paz-Ares, Laura Sanz, Luis Alvarez-Vallina
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Kasper Mølgaard Jensen, Seandean L Harwood, Marta Compte, Nekane Merino, Jaume Bonet, Ana Alvarez-Cienfuegos, Kasper Mikkelsen, Natalia Nuñez-Prado, Ana María Álvarez-Méndez, Laura Sanz, Francisco J Blanco, Luis Alvarez-Vallina
Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies. Cancer immunology, immunotherapy : CII 67 (8) (2018)

Luis Alvarez-Vallina.css-eqlu8i{font-size:small;padding-left:4px;} (Luis Álvarez-Vallina)

Publication Activity (10 Years)

Top Topics

Top Venues

Luis Alvarez-Vallina (Luis Álvarez-Vallina)